# Neumora Therapeutics, Inc.: Form 8-K, filed Sep 19, 2023

- Company: [Neumora Therapeutics, Inc.](/companies/nmra.md) (CIK 1885522)
- Form: 8-K
- Filed: 2023-09-19
- Accepted by EDGAR: Sep 19, 2023, 16:16 ET
- Period: 2023-09-19
- Accession: 0001193125-23-237644
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1885522/000119312523237644/d541406d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1885522/000119312523237644/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1885522/000119312523237644/d541406d8k.htm

Filed Sep 19, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-237644. Last ingested by Listed: Oct 30, 2026, 16:11 ET. No prices; not investment advice.